Description
Target Audience
This course is intended for practicing radiologists, nuclear medicine physicians and radiologic nurses, physician
assistants, technologists, residents, fellows and others who are interested in the clinical applications of PET
and PET/CT.
Course Description
This course provides a clinical perspective of PET/CT imaging and the emerging use of Theranostic agents within Nuclear
Medicine. A broad perspective on the economic, clinical, and academic aspects of the latest trends in PET/CT imaging
and Nuclear Medicine therapy will be presented.
Course Objectives
At the conclusion of this course, participants will be able to:
• Describe new developments in the merger of diagnostic and therapeutic radioligands for PET/CT imaging
and therapy with specific focus on DOTA, PSMA, and PRRT
• Describe the logistics of bringing these new diagnostic and therapeutic technologies to clinical practice
• Identify the key clinical indications for new emerging tracers for Neuroendocrine Tumor and Prostate cancer
using somatostatin receptor and PSMA PET/CT imaging
• Review and discuss the standard-of-care clinical application and advanced interpretation of FDG PET/CT
Reviews
There are no reviews yet.